In this real-world study of patients with type 2 diabetes, treatment with semaglutide resulted in greater reductions in body weight and hemoglobin A1c than dulaglutide.
Emily Thomas, PharmD, BCPS, BCACP
Advertisement
Articles by Emily Thomas, PharmD, BCPS, BCACP
The authors studied the impact of a pharmacist intervention on blood pressure control compared with usual care.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
NYC Legionnaires Disease Cluster Slows as Cooling Tower Remediation Continues
2
Medicaid Fraud Crackdown Intensifies, But Is It Solving the Right Problem?
3
MS Likely Unfolds Along a Continuum Years Before First Symptoms
4
FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer
5